GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Signatures Ltd (ASX:GSS) » Definitions » Other Operating Expense

Genetic Signatures (ASX:GSS) Other Operating Expense : A$12.66 Mil (TTM As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Genetic Signatures Other Operating Expense?

Genetic Signatures's Other Operating Expense for the six months ended in Dec. 2023 was A$4.95 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was A$12.66 Mil.

Genetic Signatures's quarterly Other Operating Expense increased from Dec. 2022 (A$5.36 Mil) to Jun. 2023 (A$7.71 Mil) but then declined from Jun. 2023 (A$7.71 Mil) to Dec. 2023 (A$4.95 Mil).

Genetic Signatures's annual Other Operating Expense increased from Jun. 2021 (A$7.10 Mil) to Jun. 2022 (A$9.10 Mil) and increased from Jun. 2022 (A$9.10 Mil) to Jun. 2023 (A$13.07 Mil).


Genetic Signatures Other Operating Expense Historical Data

The historical data trend for Genetic Signatures's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Signatures Other Operating Expense Chart

Genetic Signatures Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only 3.29 5.25 7.10 9.10 13.07

Genetic Signatures Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.44 4.66 5.36 7.71 4.95

Genetic Signatures Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$12.66 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genetic Signatures Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Genetic Signatures's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Genetic Signatures (ASX:GSS) Business Description

Traded in Other Exchanges
N/A
Address
7 Eliza Street, Newtown, Sydney, NSW, AUS, 2042
Genetic Signatures Ltd proprietary PCR solutions and automated workflows routinely screen for multiple infectious diseases in a single test. Rapid and accurate results facilitate improved patient management and healthcare outcomes. GSS continues to expand its global reach with direct representation in Australia, Europe, and the United States, and growing distribution partnerships. The company operates under one business segment which is the research and commercialisation of identifying individual genetic signatures to diagnose diseases and disabilities.

Genetic Signatures (ASX:GSS) Headlines